BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7513560)

  • 1. [The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
    Huppert PE; Geissler F; Duda SH; Lauchart W; Dette S; Dietz K; Brambs HJ; Claussen CD
    Rofo; 1994 May; 160(5):425-32. PubMed ID: 7513560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis.
    Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K
    Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The palliative treatment of primary hepatocellular carcinoma by chemoembolization].
    Hasan I; Wickenhöfer R; Görich J; Hartlapp JH; Reiser M
    Dtsch Med Wochenschr; 1992 Apr; 117(15):576-80. PubMed ID: 1373113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
    Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
    Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
    Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The preoperative chemoembolization of hepatocarcinoma due to cirrhosis].
    Savastano S; Feltrin GP; Miotto D; Chiesura-Corona M; Casarrubea G; Cecchetto A
    Radiol Med; 1994 Nov; 88(5):620-4. PubMed ID: 7824778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
    Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
    J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
    Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous alcohol instillation therapy (PAI) and chemoembolization in extensive hepatocellular carcinoma].
    Adamus R; Tesdal IK; Georgi M
    Rofo; 1997 Feb; 166(2):173-5. PubMed ID: 9116264
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization.
    Yu SC; Hui JW; Hui EP; Mo F; Lee PS; Wong J; Lee KF; Lai PB; Yeo W
    J Vasc Interv Radiol; 2009 Mar; 20(3):352-9. PubMed ID: 19167240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
    Iwazawa J; Ohue S; Kitayama T; Sassa S; Mitani T
    AJR Am J Roentgenol; 2011 Aug; 197(2):W337-42. PubMed ID: 21785062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multi-sequential arterial chemoembolization of advanced hepatocellular carcinomas: computerized tomography follow-up parameters for evaluating effectiveness of therapy].
    Vogl TJ; Schroeder H; Trapp M; Straub R; Schuster A; Schuster M; Mack M; Souchon F; Neuhaus P
    Rofo; 2000 Jan; 172(1):43-50. PubMed ID: 10719462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.